188 related articles for article (PubMed ID: 27685251)
1. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
[TBL] [Abstract][Full Text] [Related]
2. Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.
Bardou-Jacquet E; Lainé F; Morcet J; Perrin M; Guyader D; Deugnier Y
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):418-21. PubMed ID: 24557330
[TBL] [Abstract][Full Text] [Related]
3. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
4. Dysmetabolic iron overload syndrome.
Deugnier Y; Bardou-Jacquet É; Lainé F
Bull Acad Natl Med; 2016 Feb; 200(2):327-333. PubMed ID: 29898328
[TBL] [Abstract][Full Text] [Related]
5. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
[TBL] [Abstract][Full Text] [Related]
7. Dysmetabolic iron overload syndrome (DIOS).
Deugnier Y; Bardou-Jacquet É; Lainé F
Presse Med; 2017 Dec; 46(12 Pt 2):e306-e311. PubMed ID: 29169710
[TBL] [Abstract][Full Text] [Related]
8. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
9. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.
Brudevold R; Hole T; Hammerstrøm J
PLoS One; 2008; 3(10):e3547. PubMed ID: 18958176
[TBL] [Abstract][Full Text] [Related]
10. Dysmetabolic Iron Overload in Metabolic Syndrome.
Sachinidis A; Doumas M; Imprialos K; Stavropoulos K; Katsimardou A; Athyros VG
Curr Pharm Des; 2020; 26(10):1019-1024. PubMed ID: 32000639
[TBL] [Abstract][Full Text] [Related]
11. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
12. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
13. Liver iron overload is associated with elevated SHBG concentration and moderate hypogonadotrophic hypogonadism in dysmetabolic men without genetic haemochromatosis.
Gautier A; Lainé F; Massart C; Sandret L; Piguel X; Brissot P; Balkau B; Deugnier Y; Bonnet F
Eur J Endocrinol; 2011 Aug; 165(2):339-43. PubMed ID: 21646287
[TBL] [Abstract][Full Text] [Related]
14. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
Brigant F; Hautefeuille V; Dadban A; Lok C; Nguyen-Khac E; Chaby G
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437295
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease.
Murali AR; Gupta A; Brown K
Hepatol Res; 2018 Feb; 48(3):E30-E41. PubMed ID: 28593739
[TBL] [Abstract][Full Text] [Related]
16. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
19. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
[TBL] [Abstract][Full Text] [Related]
20. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
